Abacavir Use and Risk for Myocardial Infarction and Coronary Artery Disease: Updated Meta-analysis of Data from Clinical Trials

Cassandra Nan,Mark S. Shaefer,Rimgaile Urbaityte,James Oyee,Judy Hopking,Leigh Ragone,Cynthia McCoig,Vani Vannappagari

Abacavir Use and Risk for Myocardial Infarction and Coronary Artery Disease: Updated Meta-analysis of Data from Clinical Trials

2017

Cassandra Nan
Mark S. Shaefer
Rimgaile Urbaityte
James Oyee
Judy Hopking
Leigh Ragone
Cynthia McCoig
Vani Vannappagari

Background Several observational studies and randomized controlled trials (RCTs) have suggested an association between abacavir (ABC) use and myocardial infarction (MI) but others, including meta-analyses of clinical trial data, have not.

Keywords:

Abacavir
Clinical trial
Intensive care medicine
Immune reconstitution inflammatory syndrome
Meta-analysis
Coronary artery disease
Medicine
Diabetes mellitus
Myocardial infarction
Observational study
Randomized controlled trial
Physical therapy
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations